0

Cardiac Prosthetic Devices Market by Product and Geography - Forecast and Analysis 2022-2026

  • Published: Jun 2022
  • Pages: 138
  • SKU: IRTNTR73779
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The cardiac prosthetic devices market share is expected to increase to USD 5.87 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 8.02%.

This cardiac prosthetic devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers cardiac prosthetic devices market segmentation by product (prosthetic heart valves and implantable pacemakers) and geography (North America, Europe, Asia, and Rest of World (ROW)). The cardiac prosthetic devices market report also offers information on several market vendors, including Abbott Laboratories, Anteris Technologies Ltd., BIOTRONIK SE and Co KG, Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Cryolife Inc., Edwards Lifesciences Corp., Jc Medical Inc., JenaValve Technology Inc., Lepu Medical Technology Beijing Co. Ltd., LivaNova Plc, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Merit Medical Systems Inc., MicroPort Scientific Corp., OrbusNeich Medical Co. Ltd., Shree Pacetronix Ltd., TTK Healthcare Ltd., and Venus Medtech Hangzhou Inc. among others.

What will the Cardiac Prosthetic Devices Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Cardiac Prosthetic Devices Market Size for the Forecast Period and Other Important Statistics

 

Cardiac Prosthetic Devices Market: Key Drivers, Trends, and Challenges

The rising prevalence of cardiac disorders is notably driving the cardiac prosthetic devices market growth, although factors such as complications associated with implantation of cardiac prosthetic devices may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cardiac prosthetic devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Cardiac Prosthetic Devices Market Driver

  • One of the key factors driving the global cardiac prosthetic devices market growth is the rising prevalence of cardiac disorders such as bradycardia, valvular diseases, atrioventricular blocks, cardiac arrest, and tachycardia.
  • In 2020, CVD accounted for approximately 19.05 million global deaths.
  • The growing implantation of prosthetic cardiac valves for the treatment of the mitral valve and hemodynamically significant aortic-related disease has gained greater importance in recent years.
  • The vendors are developing new cardiac prosthetic devices to cater to the market demand.
  • Cardiac rhythm management devices such as implantable cardiac pacemakers can be used as a rapid lifesaving measure for a person with sudden cardiac arrest.
  • In September 2021, Abbott Laboratories announced that the US FDA had approved the Portico with FlexNav TAVR system. It will treat people with symptomatic, severe AS at high or extreme risk for open-heart surgery.
  • The rising prevalence of cardiac disorders will lead to growth in the market in focus during the forecast period.

Key Cardiac Prosthetic Devices Market Trend

  • Advances in technology is one of the key cardiac prosthetic devices market trends that is expected to impact the industry positively in the forecast period.
  • The evolution in valve surgery has been revolutionized owing to technological upgrading, which has led to better post-surgery outcomes.
  • The vendors are competing technologically, and the manufacturers such as plc Medtronic and Edwards Lifesciences have a strong presence in the global market owing to the wide range of technologically advanced products in their products category.
  • In March 2022, Medtronic plc announced it had received US FDA approval for its Harmony TPV, the first minimally invasive therapy created to treat patients with a particular type of congenital heart defect of the RV.
  • In September 2020, Boston Scientific Corp. announced it had initiated a controlled launch of the ACURATE neo2 Aortic Valve System in Europe, which is designed with a number of features to improve the clinical performance of the original ACURATE neo platform.
  • The recent technology addition by the leading vendors will further support the concerned market growth in the forecast years.

Key Cardiac Prosthetic Devices Market Challenge

  • One of the key challenges to the global cardiac prosthetic devices market growth is the complications associated with the implantation of cardiac prosthetic devices.
  • The serious complications associated with TAVI include vascular injuries, stroke, and structural injury to the aorta, heart, and valves.
  • The rate of acute complications with pacemaker insertion arises within a day and is higher as compared to the incidence of late complications of a permanent pacemaker.
  • The complications associated with the pacemaker implantations include infection near the implanted area, bleeding, bruising, and swelling associated with the patient using blood thinners.
  • The blood vessels and nerve damage near the pacemaker lead to lung collapse.
  • Major operative failures such as pneumothorax, pericarditis, air embolism, hemothorax, erosion of the pacer, and hematomas are some of the other life-threatening complications associated with the pacemaker implantation.
  • The range of serious complications associated with cardiac prosthetic device implantation procedures and devices will restrain the market growth in the forecast years.

This cardiac prosthetic devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global cardiac prosthetic devices market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the cardiac prosthetic devices market during the forecast period.

Who are the Major Cardiac Prosthetic Devices Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • BIOTRONIK SE and Co KG
  • Boston Scientific Corp.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • Cryolife Inc.
  • Edwards Lifesciences Corp.
  • Jc Medical Inc.
  • JenaValve Technology Inc.
  • Lepu Medical Technology Beijing Co. Ltd.
  • LivaNova Plc
  • Medtronic Plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems Inc.
  • MicroPort Scientific Corp.
  • OrbusNeich Medical Co. Ltd.
  • Shree Pacetronix Ltd.
  • TTK Healthcare Ltd.
  • Venus Medtech Hangzhou Inc.

 

This statistical study of the cardiac prosthetic devices market encompasses successful business strategies deployed by the key vendors. The cardiac prosthetic devices market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

  • Abbott Laboratories - The company offers cardiac prosthetic devices that are designed to offer performance in 3 key areas which are hemodynamics, durability, and implantability.
  • BIOTRONIK SE and Co KG - The company offers cardiac prosthetic devices with external PET skirting to plug microchannels that is used for minimally invasive surgical treatment of calcifying aortic stenosis in a native valve.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The cardiac prosthetic devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Cardiac Prosthetic Devices Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the cardiac prosthetic devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Cardiac Prosthetic Devices Market?

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for cardiac prosthetic devices in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The high prevalence of heart disorders such as CHD, and rise in the adoption of tissue valves, the increase in the adoption of MI procedures, and the growing geriatric population will facilitate the cardiac prosthetic devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The COVID-19 pandemic has had a far-reaching impact on various industries in North America. During the COVID-19 phase, the US has suffered a lack of proper medical services for heart surgeries due to the limited availability of beds and other healthcare facilities. However, the market has been growing positively since 2021, as the disease has been brought under control with the advent of COVID-19 vaccines. The outbreak also prompted vendors to develop new business strategies, such as online promotional activities and training for doctors, to raise the demand for healthcare equipment. This will help the regional market to grow during the forecast period.

What are the Revenue-generating Product Segments in the Cardiac Prosthetic Devices Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The cardiac prosthetic devices market share growth by the prosthetic heart valve segment will be significant during the forecast period. The continuous product development by the key vendors such as Abbott Laboratories, Edwards Lifesciences Corp., and others, and the involvement of the key players, along with the rise in procedural volume is anticipated to drive the segment growth in the forecast years. For instance, in December 2021, Edwards Lifesciences Corp. announced to broaden the adoption of its flagship aortic surgical heart valve, INSPIRIS RESILIA, along with the KONECT RESILIA valved conduit. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the cardiac prosthetic devices market size and actionable market insights on post COVID-19 impact on each segment.

 

Cardiac Prosthetic Devices Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 8.02%

Market growth 2022-2026

$ 5.87 billion

Market structure

Fragmented

YoY growth (%)

7.42

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Anteris Technologies Ltd., BIOTRONIK SE and Co KG, Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Cryolife Inc., Edwards Lifesciences Corp., Jc Medical Inc., JenaValve Technology Inc., Lepu Medical Technology Beijing Co. Ltd., LivaNova Plc, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Merit Medical Systems Inc., MicroPort Scientific Corp., OrbusNeich Medical Co. Ltd., Shree Pacetronix Ltd., TTK Healthcare Ltd., and Venus Medtech Hangzhou Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Cardiac Prosthetic Devices Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive cardiac prosthetic devices market growth during the next five years
  • Precise estimation of the cardiac prosthetic devices market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the cardiac prosthetic devices industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of cardiac prosthetic devices market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 Prosthetic heart valves - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Prosthetic heart valves - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Prosthetic heart valves - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Prosthetic heart valves - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Prosthetic heart valves - Year-over-year growth 2021-2026 (%)
    • 5.4 Implantable pacemakers - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Implantable pacemakers - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Implantable pacemakers - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Implantable pacemakers - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Implantable pacemakers - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Product
      • Exhibit 36: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Abbott Laboratories
              • Exhibit 85: Abbott Laboratories - Overview
              • Exhibit 86: Abbott Laboratories - Business segments
              • Exhibit 87: Abbott Laboratories - Key news
              • Exhibit 88: Abbott Laboratories - Key offerings
              • Exhibit 89: Abbott Laboratories - Segment focus
            • 10.4 BIOTRONIK SE and Co KG
              • Exhibit 90: BIOTRONIK SE and Co KG - Overview
              • Exhibit 91: BIOTRONIK SE and Co KG - Product / Service
              • Exhibit 92: BIOTRONIK SE and Co KG - Key offerings
            • 10.5 Boston Scientific Corp.
              • Exhibit 93: Boston Scientific Corp. - Overview
              • Exhibit 94: Boston Scientific Corp. - Business segments
              • Exhibit 95: Boston Scientific Corp. - Key news
              • Exhibit 96: Boston Scientific Corp. - Key offerings
              • Exhibit 97: Boston Scientific Corp. - Segment focus
            • 10.6 Colibri Heart Valve LLC
              • Exhibit 98: Colibri Heart Valve LLC - Overview
              • Exhibit 99: Colibri Heart Valve LLC - Product / Service
              • Exhibit 100: Colibri Heart Valve LLC - Key offerings
            • 10.7 Cryolife Inc.
              • Exhibit 101: Cryolife Inc. - Overview
              • Exhibit 102: Cryolife Inc. - Business segments
              • Exhibit 103: Cryolife Inc. - Key offerings
              • Exhibit 104: Cryolife Inc. - Segment focus
            • 10.8 Edwards Lifesciences Corp.
              • Exhibit 105: Edwards Lifesciences Corp. - Overview
              • Exhibit 106: Edwards Lifesciences Corp. - Business segments
              • Exhibit 107: Edwards Lifesciences Corp. - Key offerings
              • Exhibit 108: Edwards Lifesciences Corp. - Segment focus
            • 10.9 Lepu Medical Technology Beijing Co. Ltd.
              • Exhibit 109: Lepu Medical Technology Beijing Co. Ltd. - Overview
              • Exhibit 110: Lepu Medical Technology Beijing Co. Ltd. - Product / Service
              • Exhibit 111: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
            • 10.10 LivaNova Plc
              • Exhibit 112: LivaNova Plc - Overview
              • Exhibit 113: LivaNova Plc - Business segments
              • Exhibit 114: LivaNova Plc - Key offerings
              • Exhibit 115: LivaNova Plc - Segment focus
            • 10.11 Medtronic Plc
              • Exhibit 116: Medtronic Plc - Overview
              • Exhibit 117: Medtronic Plc - Business segments
              • Exhibit 118: Medtronic Plc - Key news
              • Exhibit 119: Medtronic Plc - Key offerings
              • Exhibit 120: Medtronic Plc - Segment focus
            • 10.12 Meril Life Sciences Pvt. Ltd.
              • Exhibit 121: Meril Life Sciences Pvt. Ltd. - Overview
              • Exhibit 122: Meril Life Sciences Pvt. Ltd. - Product / Service
              • Exhibit 123: Meril Life Sciences Pvt. Ltd. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 124: Inclusions checklist
                • Exhibit 125: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 126: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 127: Research methodology
                • Exhibit 128: Validation techniques employed for market sizing
                • Exhibit 129: Information sources
              • 11.5 List of abbreviations
                • Exhibit 130: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The cardiac prosthetic devices market market growth will increase by $$ 5.87 billion during 2023-2026.
              The cardiac prosthetic devices market market is expected to grow at a CAGR of 8.02% during 2023-2026.
              Technavio has segmented the cardiac prosthetic devices market market by product (Prosthetic heart valves and Implantable pacemakers) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Abbott Laboratories, Anteris Technologies Ltd., BIOTRONIK SE and Co KG, Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Cryolife Inc., Edwards Lifesciences Corp., Jc Medical Inc., JenaValve Technology Inc., Lepu Medical Technology Beijing Co. Ltd., LivaNova Plc, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Merit Medical Systems Inc., MicroPort Scientific Corp., OrbusNeich Medical Co. Ltd., Shree Pacetronix Ltd., TTK Healthcare Ltd., Venus Medtech Hangzhou Inc. are a few of the key vendors in the cardiac prosthetic devices market market.
              North America will register the highest growth rate of 42% among the other regions. Therefore, the cardiac prosthetic devices market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the cardiac prosthetic devices market market growth are:
              • Rising prevalence of cardiac disorders
              • Advances in technology
              The cardiac prosthetic devices market market vendors should focus on grabbing business opportunities from the prosthetic heart valves segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>